GN Store Nord A/S (CPH:GN)
93.94
-1.32 (-1.39%)
May 19, 2026, 12:14 PM CET
GN Store Nord Revenue
GN Store Nord had revenue of 2.10B DKK in the quarter ending March 31, 2026, a decrease of -8.19%. This brings the company's revenue in the last twelve months to 16.60B, up 3.95% year-over-year. In the year 2025, GN Store Nord had annual revenue of 16.78B, down -6.69%.
Revenue (ttm)
16.60B
Revenue Growth
+3.95%
P/S Ratio
0.84
Revenue / Employee
2.15M
Employees
7,736
Market Cap
13.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.78B | -1.20B | -6.69% |
| Dec 31, 2024 | 17.99B | -135.00M | -0.75% |
| Dec 31, 2023 | 18.12B | -567.00M | -3.03% |
| Dec 31, 2022 | 18.69B | 2.91B | 18.46% |
| Dec 31, 2021 | 15.78B | 2.33B | 17.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| H. Lundbeck | 25.52B |
| Genmab | 25.29B |
| Zealand Pharma | 9.24B |
| ALK-Abelló | 6.56B |
| Embla Medical | 6.21B |
| Ambu A/S | 6.10B |
GN Store Nord News
- 3 days ago - Trading in GN Store Nord shares by board members, executives and associated persons - GlobeNewsWire
- 11 days ago - GN Store Nord Slips To Loss In Q1; Sees Margin Growth In FY26; Stock Down - Nasdaq
- 12 days ago - GN Store Nord Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - GN Store Nord A/S: Guidance updated to reflect Hearing business being treated as discontinued operations - Finanz Nachrichten
- 12 days ago - GN Store Nord A/S: Interim Report Q1 2026: Navigating challenging markets in EMEA and taking actions to adjust the cost structure for future healthy margins - Finanz Nachrichten
- 2 months ago - Trading in GN Store Nord shares by board members, executives and associated persons - GlobeNewsWire
- 2 months ago - GN Store Nord Transcript: M&A announcement - Transcripts
- 2 months ago - GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion - GlobeNewsWire